Raymond James Financial Inc. acquired a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 233,657 shares of the company's stock, valued at approximately $3,066,000. Raymond James Financial Inc. owned about 0.27% of Pediatrix Medical Group at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of MD. Proficio Capital Partners LLC purchased a new stake in Pediatrix Medical Group in the fourth quarter valued at $404,000. M&T Bank Corp increased its position in shares of Pediatrix Medical Group by 16.2% during the 4th quarter. M&T Bank Corp now owns 99,090 shares of the company's stock worth $1,300,000 after purchasing an additional 13,826 shares during the last quarter. Victory Capital Management Inc. raised its holdings in Pediatrix Medical Group by 95.8% in the 4th quarter. Victory Capital Management Inc. now owns 76,553 shares of the company's stock valued at $1,004,000 after buying an additional 37,463 shares during the period. Bailard Inc. purchased a new stake in Pediatrix Medical Group in the 4th quarter valued at about $161,000. Finally, Smartleaf Asset Management LLC lifted its position in Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after buying an additional 6,090 shares during the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.
Pediatrix Medical Group Stock Up 2.2 %
Shares of NYSE MD traded up $0.32 during mid-day trading on Wednesday, hitting $14.83. The company had a trading volume of 501,596 shares, compared to its average volume of 835,774. The company has a market capitalization of $1.27 billion, a PE ratio of -12.36, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. The business's 50-day simple moving average is $14.44 and its 200 day simple moving average is $13.75. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.
Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to analysts' expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. On average, analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of research firms have recently issued reports on MD. Macquarie started coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an "outperform" rating and a $18.00 price objective on the stock. Truist Financial boosted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research report on Friday, February 21st. UBS Group raised their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a research report on Friday, February 21st. Finally, StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $17.08.
Read Our Latest Stock Analysis on MD
About Pediatrix Medical Group
(
Free Report)
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Featured Stories

Before you consider Pediatrix Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.
While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.